Related Experiment Videos
[Color Doppler in breast tumor pathology].
C Balu-Maestro1, J N Bruneton, T Giudicelli
1Service de Radiologie, Centre Antoine-Lacassagne, Nice.
Journal De Radiologie
|November 1, 1991
Summary
Colour Doppler imaging shows abnormal blood flow in most breast cancers and metastatic lymph nodes. While not ideal for distinguishing benign from malignant breast tumors, it aids chemotherapy follow-up and accurately diagnoses metastatic lymph nodes.
Area of Science:
- Medical Imaging
- Oncology
- Radiology
Background:
- Colour Doppler ultrasound is a non-invasive imaging technique.
- Assessing vascularity in breast lesions and lymph nodes can aid diagnosis.
- Limited data exists on Colour Doppler's utility in breast cancer follow-up and lymph node staging.
Purpose of the Study:
- To evaluate the role of Colour Doppler findings in breast tumors and lymph node enlargements.
- To determine the diagnostic value of Colour Doppler in differentiating benign from malignant breast lesions.
- To assess the utility of Colour Doppler in monitoring chemotherapy response and diagnosing metastatic lymph nodes.
Main Methods:
- Retrospective analysis of Colour Doppler ultrasound findings.
- Inclusion of 63 breast tumors and 19 lymph node enlargements.
- Correlation of Doppler signals with tumor characteristics and clinical outcomes.
Main Results:
- Abnormal Colour Doppler signals were detected in 68.5% of cancers, 42.8% of metastatic lymph nodes, and 10% of benign lesions.
- Bidirectional flow was observed in 80% of cases.
- Colour Doppler showed limited value in differentiating malignant from benign breast tumors but demonstrated 100% specificity for diagnosing metastatic lymph nodes.
- Partial regression of Doppler signals correlated with tumor volume reduction during chemotherapy.
Conclusions:
- Colour Doppler ultrasound is highly specific (100%) for diagnosing metastatic lymph nodes.
- It is valuable for monitoring chemotherapy response in breast cancer by assessing signal and volume regression.
- Interpretation can be challenging after conservative breast cancer treatment due to post-radiotherapy changes.